Global Subcutaneous Self-Administration Injection Devices Markets 2021-2028: Products, Drug Delivery and Device Strategies, and Product Development Factors

News provided by

Nov 01, 2021, 12:15 ET

DUBLIN, Nov. 1, 2021 /PRNewswire/ -- The "Injection Devices for Subcutaneous Self-Administration" report has been added to ResearchAndMarkets.com's offering.

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver.

For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

Injection Devices for Subcutaneous Self-administration- What You Will Learn

Provides detailed analysis of subcutaneous drug products, drug delivery and device strategies, and product development factors
Assesses key markets, market dynamics and market demographics
Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
Provides market data and forecasts to 2028
Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
Assesses the importance of alliances and partnerships on subcutaneous drug product commercialization
Evaluates the impact of economic, technology, and regulatory factor

Key Topics Covered:

Executive Summary
The Market Opportunity
Delivery Market Dynamics
The Economics of Injectable Drugs
What's Driving the Growth in Injectable Devices?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Proliferation of Biological Drugs
Therapeutic Monoclonal Antibodies
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors
Autoinjectors - Commercial Devices
Manual Injection Autoinjectors
Automated Injection Autoinjectors
Disposable Autoinjectors
Development-stage Autoinjectors
Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics
Pen Injectors
Pen Injector Design Selection Factors
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Dual Chamber Pens
Commercial Pen Products
Parathyroid Hormone
Wearable Devices - Product Analysis and Assessments
Electronic Semi-disposable
Wireless Data
Key Therapeutic Sector Analysis
Anaphylaxis/Countermeasures
Autoimmune Diseases
Rheumatoid Arthritis
Psoriasis
Multiple Sclerosis
Exenatide (Byetta)
Bydureon
Pramlinitide (Symlin)
Abliglutide (Tanzeum)
Hepatitis
Hormones
Osteoporosis
Market Factors
Regulatory Issues
Device Branding
Patient Adherence and Ease of Use
Healthcare Economics

Company Profiles

SHL Medical
Consort Medical
West Pharmaceutical Services
Elcam Medical
Aptar
Ypsomed
Oval Medical
Bayer
Merck Serono
Dr. Reddy's
Novartis
Amgen
Genetech
Roche
Antares Pharma
Midas Pharma
Owen Mumford
Sensile Medical
Becton Dickinson
SteadyMed
scPharmaceuticals
Terumo
PA Consulting

For more information about this report visit https://www.researchandmarkets.com/r/76nrlv

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets